Shares of Abbott Labs (ABT +1%) tick higher after being initiated by analysts at Stifel Nicolaus...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Shares of Abbott Labs (ABT +1%) tick higher after being initiated by analysts at Stifel Nicolaus with a Buy and a price target of $40 per share, noting that the drug giant is a solid performer that delivers reliable and consistent earnings growth.